Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 1,719 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Positive control Clear all

Conditions: Chronic Hepatitis B Infection
Interventions: ALG-000184, TDF; Drug
Lead sponsor: Aligos Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 6
States / cities: Coronado, California • Pasadena, California • Rialto, California + 3 more

Conditions: Post Operative Surgical Site Infection
Interventions: Standard of care, Vancomycin and Tobramycin; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 64 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 31
States / cities: Redwood City, California • San Francisco, California • Aurora, Colorado + 25 more

Conditions: Kidney Transplantation in Highly Sensitized Patients
Interventions: Imlifidase, PLEX, IVIg, Anti-CD20 antibodies, Eculizumab, Remain on wait list; Drug · Procedure · Other
Lead sponsor: Hansa Biopharma AB; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 25
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 16 more

Conditions: Head and Neck Cancer, Body Image Disturbance, Body Image, Survivorship, Psychosocial Impairment, Mental Health Issue
Interventions: BRIGHT, Attention Control; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 5
States / cities: Detroit, Michigan • St Louis, Missouri • Hershey, Pennsylvania + 2 more

Conditions: Program Evaluation, Child Sexual Abuse, Perpetration of Child Sexual Abuse, Prevention Intervention
Interventions: Help Wanted Prevention Intervention, Waitlist Control; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Male only
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Childhood Obesity
Interventions: FBT 2.0, Delayed-Start Control (AAP educational materials); Behavioral
Lead sponsor: 3-C Institute for Social Development; Industry
Eligibility: 6 Years and older
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Respiratory Distress Syndrome
Interventions: Gradual pressure wean; Other
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 26 Weeks to 32 Weeks
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed, SARS CoV 2 Infection
Interventions: RQ-001, Placebo; Combination Product · Other
Lead sponsor: Red Queen Therapeutics, Inc.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 6
States / cities: Los Angeles, California • Miami, Florida • Baltimore, Maryland + 3 more

Conditions: Character, Violence, Substance Use, Pro-social Behavior, Academic Achievement
Interventions: Positive Action; Behavioral
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 6 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2006
U.S. locations: 3
States / cities: Twin Falls, Idaho • Chicago, Illinois • Corvallis, Oregon

Conditions: Sleep Apnea, Obstructive, Craniofacial Abnormalities, Pediatric Disorder
Interventions: Personalized continuous positive airway pressure (CPAP) mask; Device
Lead sponsor: Glenn Green; Other
Eligibility: 1 Year to 18 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Situational Anxiety, Behavior
Interventions: Therapy dog presence, Standard-of-care basic behavior guidance; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 4 Years to 12 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Aging, Aging, Healthy, Aging Well, Aging, Biological
Interventions: Positive Emotion Skills Intervention; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 40 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Sinusitis
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Generalized Anxiety Disorder
Interventions: ENX-102, Placebo; Drug
Lead sponsor: Engrail Therapeutics INC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 32
States / cities: Phoenix, Arizona • Garden Grove, California • Imperial, California + 29 more

Conditions: Obstructive Sleep Apnea, Hypertonia, Muscle, Nasal Airway Obstruction, Tolerance, Trisomy 21, Down Syndrome
Interventions: Self-Supporting Nasopharyngeal Airway (ssNPA); Device
Lead sponsor: University of Michigan; Other
Eligibility: 3 Years to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Human Immunodeficiency Virus (HIV) Positive
Interventions: Positive Health Check, Standard of Care; Behavioral
Lead sponsor: RTI International; Other
Eligibility: 18 Years and older
Enrollment: 799 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 4
States / cities: Tampa, Florida • Atlanta, Georgia • New Orleans, Louisiana + 1 more

Conditions: Urinary Tract Infections
Interventions: Not listed
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: Not listed
Enrollment: 919 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 2
States / cities: Los Angeles, California • Torrance, California

Conditions: Brain Injuries, Traumatic
Interventions: TIPS Intervention, Control; Behavioral
Lead sponsor: University of Oregon; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Survivorship, Cancer, Psychological Well-Being
Interventions: an empirically supported protocol, further refined with evidence-based strategies, Health education; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Tuberculosis
Interventions: DAR-901, BCG, Sterile saline; Biological
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Allergic Rhinitis
Interventions: saline with 1mg/ml Histamine base, diluent, saline with HSA--phenol; Drug
Lead sponsor: Bryan Martin, DO; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Suicide, Interpersonal Relations
Interventions: VA Standard Suicide Intervention, Treatment for Relationships and Safety Together (TR&ST); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: San Diego, California

Conditions: Breast Cancer
Interventions: Everolimus, Exemestane, Everolimus Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 724 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 63
States / cities: Chandler, Arizona • Fayetteville, Arkansas • Anaheim, California + 54 more

Conditions: Opioid Use, Pregnancy Related
Interventions: MORE, Supportive Psychotherapy; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

Help Wanted: Evaluating a Prevention Intervention for People With Sexual Interest in Children

Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity

Comparing Weaning of Nasal Continuous Positive Airway Pressure (CPAP) From Preterm Infants

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

Randomized Trial of the Positive Action Program in Hawaii Schools

3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea

Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures

Emotional Well-being and Measures of Healthy Aging

Genetic Factors in Chronic Sinusitis

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

Positive Health Check Evaluation Trial

The Significance of Funguria in Hospitalized Patients

Traumatic Brain Injury Positive Strategies

mHealth for Young Adult Cancer Survivors

Phase I Trial of DAR-901

Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests

Treatment for Relationships and Safety Together

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

Serving Women Using Opioids During Pregnancy